Claris Lifesciences
CLARISLIFE · Retail > Trading Listing date: Dec. 20, 2010

Stock Price vs Company Growth
5y
0.0%
10y
5.8%
all
4.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 397 0%
N/A
397
Company Overview

Sales
11.7 Cr
Growth: -62.2%
Profit after Tax
54 Cr
Growth: -604.8%
Unknown Cap
N/A Cr
P/E: 1.6x
Industry P/E: 28.6x
Fundamentals

Sales (Cr) ₹ 11.7
Growth -62.2%
EBITDA -467.0%
P/S N/A
Dividend 0.0%
P/E 1.6x
Book Value ₹ N/A
PEG Ratio -0.0x
ROE 6.9%
P/B 0.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

:Claris Lifesciences is one of the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Their product offering comprises of 113 products across multiple markets and therapeutic areas. All of its products are off-patent products, a significant majority of which are capable of being directly injected into the body and are predominantly used in the treatment of critical illnesses.
Investors (3)